Background: Sleep apnea is common in hospitalized heart failure (HF) patients and is
associated with increased morbidity and mortality. Objectives: The CAT-HF (Cardiovascular …

Sleep‐disordered breathing—comprising obstructive sleep apnoea (OSA), central sleep
apnoea (CSA), or a combination of the two—is found in over half of heart failure (HF) …

Background Central sleep apnea is associated with poor prognosis and death in patients
with heart failure. Adaptive servo-ventilation is a therapy that uses a noninvasive ventilator to …

Background Adaptive servoventilation (ASV) has demonstrated efficacy in treating sleep-
disordered breathing (SDB) in patients with heart failure (HF), but large randomized trials …

Background: Adaptive servo-ventilation (ASV) therapy is expected to be novel
nonpharmacotherapy with hemodynamic effects on patients with chronic heart failure (CHF) …

Rationale Adaptive servo ventilation (ASV) is contraindicated in patients with systolic heart
failure (HF) who have a left ventricular ejection fraction (LVEF) below 45% and predominant …

BACKGROUND: Congestive heart failure (CHF) patients often present with obstructive and
central sleep apnea occurring concurrently within the same night. This study assessed the …

Introduction Both types of sleep‐disordered breathing (SDB), obstructive and central sleep
apnoea (OSA and CSA, respectively), are common in patients with heart failure and reduced …

Background: This study tested the hypothesis that adaptive servo-ventilation (ASV) therapy
improves the prognosis of heart failure (HF) patients, regardless of the severity of sleep …

Aims Central sleep apnoea/Cheyne–Stokes respiration (CSA/CSR) is a risk factor for
increased mortality and morbidity in heart failure (HF). Adaptive servo‐ventilation (ASV) is a …